CD70‐targeting CAR‐T cells have potential activity against CD19‐negative B‐cell Lymphoma

The response to lymphodepletion impacts PFS in aggressive non-Hodgkin lymphoma patients treated with CD19 CAR-T cells

(2019) Alexandre V. Hirayama et al.   BLOOD

Chimeric antigen receptor T cells targeting CD79b show efficacy in lymphoma with or without co-targeting CD19

(2019) Maria Ormhøj et al.   CLINICAL CANCER RESEARCH

Screening a Broad Range of Solid and Haematological Tumour Types for CD70 Expression Using a Uniform IHC Methodology as Potential Patient Stratification Method

(2019) Tal Flieswasser et al.   Cancers

Engineering strategies to overcome the current roadblocks in CAR T cell therapy

(2019) Sarwish Rafiq et al.   Nature Reviews Clinical Oncology

A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma

(2018) Tycel Phillips et al.   INVESTIGATIONAL NEW DRUGS

Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent

(2017) Diogo Gomes-Silva et al.   Cell Reports

Preclinical Evaluation of Chimeric Antigen Receptors Targeting CD70-Expressing Cancers

(2016) Qiong J. Wang et al.   CLINICAL CANCER RESEARCH